Cargando…

In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data

PURPOSE: Heart failure (HF) is a serious public health burden that is rapidly increasing in the aging population. Valvular heart disease (VHD) is a known etiology of heart failure (HF); however, the impact of VHD on outcomes of patients with HF has not been well-studied in Japan. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Izumi, Chisato, Matsuyama, Rei, Yamabe, Kaoru, Iwasaki, Kosuke, Takeshima, Tomomi, Murphy, Shannon M E, Teng, Lida, Igarashi, Ataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202112/
https://www.ncbi.nlm.nih.gov/pubmed/37223825
http://dx.doi.org/10.2147/CEOR.S405079
_version_ 1785045375872139264
author Izumi, Chisato
Matsuyama, Rei
Yamabe, Kaoru
Iwasaki, Kosuke
Takeshima, Tomomi
Murphy, Shannon M E
Teng, Lida
Igarashi, Ataru
author_facet Izumi, Chisato
Matsuyama, Rei
Yamabe, Kaoru
Iwasaki, Kosuke
Takeshima, Tomomi
Murphy, Shannon M E
Teng, Lida
Igarashi, Ataru
author_sort Izumi, Chisato
collection PubMed
description PURPOSE: Heart failure (HF) is a serious public health burden that is rapidly increasing in the aging population. Valvular heart disease (VHD) is a known etiology of heart failure (HF); however, the impact of VHD on outcomes of patients with HF has not been well-studied in Japan. This study aimed to determine the rates of VHD in Japanese patients admitted for HF and explore associations of VHD with in-hospital outcomes through a claim-based analysis. PATIENTS AND METHODS: We analyzed claims data from 86,763 HF hospitalizations (January 2017 through December 2019) from the Medical Data Vision database. Common etiologies of HF were examined, then hospitalizations were categorized into those with VHD and those without. Covariate-adjusted models were used to explore the association of VHD with in-hospital mortality, length of stay, and medical cost. RESULTS: Of 86,763 hospitalizations for HF, 13,183 had VHD and 73,580 did not. VHD was the second most frequent etiology of HF (15.2%). The most frequent type of VHD was mitral regurgitation (36.4% of all hospitalizations with VHD), followed by aortic stenosis (33.7%) and aortic regurgitation (16.4%). There was no significant difference in in-hospital mortality between hospitalizations with VHD vs those without (9.0% vs 8.9%; odds ratio [95% CI]: 1.01 [0.95–1.08]; p=0.723). Hospitalizations with VHD were associated with significantly longer length of stay (26.1 vs 24.8 days; incident rate ratio [95% CI]: 1.05 [1.03–1.07]; p<0.001) and higher medical costs (1536 vs 1195 thousand yen; rate ratio [95% CI]: 1.29 [1.25–1.32]; p<0.001). CONCLUSION: VHD was a frequent etiology of HF that was associated with significant medical resource use. Future studies are needed to investigate whether timely VHD treatment could reduce HF progression and its associated healthcare resource utilization.
format Online
Article
Text
id pubmed-10202112
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102021122023-05-23 In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data Izumi, Chisato Matsuyama, Rei Yamabe, Kaoru Iwasaki, Kosuke Takeshima, Tomomi Murphy, Shannon M E Teng, Lida Igarashi, Ataru Clinicoecon Outcomes Res Original Research PURPOSE: Heart failure (HF) is a serious public health burden that is rapidly increasing in the aging population. Valvular heart disease (VHD) is a known etiology of heart failure (HF); however, the impact of VHD on outcomes of patients with HF has not been well-studied in Japan. This study aimed to determine the rates of VHD in Japanese patients admitted for HF and explore associations of VHD with in-hospital outcomes through a claim-based analysis. PATIENTS AND METHODS: We analyzed claims data from 86,763 HF hospitalizations (January 2017 through December 2019) from the Medical Data Vision database. Common etiologies of HF were examined, then hospitalizations were categorized into those with VHD and those without. Covariate-adjusted models were used to explore the association of VHD with in-hospital mortality, length of stay, and medical cost. RESULTS: Of 86,763 hospitalizations for HF, 13,183 had VHD and 73,580 did not. VHD was the second most frequent etiology of HF (15.2%). The most frequent type of VHD was mitral regurgitation (36.4% of all hospitalizations with VHD), followed by aortic stenosis (33.7%) and aortic regurgitation (16.4%). There was no significant difference in in-hospital mortality between hospitalizations with VHD vs those without (9.0% vs 8.9%; odds ratio [95% CI]: 1.01 [0.95–1.08]; p=0.723). Hospitalizations with VHD were associated with significantly longer length of stay (26.1 vs 24.8 days; incident rate ratio [95% CI]: 1.05 [1.03–1.07]; p<0.001) and higher medical costs (1536 vs 1195 thousand yen; rate ratio [95% CI]: 1.29 [1.25–1.32]; p<0.001). CONCLUSION: VHD was a frequent etiology of HF that was associated with significant medical resource use. Future studies are needed to investigate whether timely VHD treatment could reduce HF progression and its associated healthcare resource utilization. Dove 2023-05-18 /pmc/articles/PMC10202112/ /pubmed/37223825 http://dx.doi.org/10.2147/CEOR.S405079 Text en © 2023 Izumi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Izumi, Chisato
Matsuyama, Rei
Yamabe, Kaoru
Iwasaki, Kosuke
Takeshima, Tomomi
Murphy, Shannon M E
Teng, Lida
Igarashi, Ataru
In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
title In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
title_full In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
title_fullStr In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
title_full_unstemmed In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
title_short In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data
title_sort in-hospital outcomes of heart failure patients with valvular heart disease: insights from real-world claims data
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202112/
https://www.ncbi.nlm.nih.gov/pubmed/37223825
http://dx.doi.org/10.2147/CEOR.S405079
work_keys_str_mv AT izumichisato inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT matsuyamarei inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT yamabekaoru inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT iwasakikosuke inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT takeshimatomomi inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT murphyshannonme inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT tenglida inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata
AT igarashiataru inhospitaloutcomesofheartfailurepatientswithvalvularheartdiseaseinsightsfromrealworldclaimsdata